Skip to main content

Rybelsus® vs. Placebo in Drug-Naïve Adults (PIONEER 1 Study)

This video discusses the trial-design and outcomes of the PIONEER 1 study. PIONEER 1 was a 26-week, phase 3a, randomized, double-blind, parallel group, multinational trial in 703 adult patients with type 2 diabetes managed with diet and exercise alone.

Play
Pause
Skip
Volume
Chapters
Transcript
References
video_su
Fullscreen

Rybelsus® vs. Placebo in Drug-Naïve Adults (PIONEER 1 Study)

Chapters
Transcript
References

Return to overview

Transcripts

Return to overview

References